ibandronic acid has been researched along with Pyrexia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, SG; Jiang, ZF; Li, LQ; Song, ST; Wang, T; Wang, YJ; Zhu, J | 1 |
| Body, JJ; Clemens, MR; Degardin, M; Herrmann, Z; Huss, HJ; Manegold, C; Pecherstorfer, M; Steinhauer, EU; Thiébaud, D; Thürlimann, B; Tubiana-Hulin, M; van Eijkeren, M | 1 |
2 trial(s) available for ibandronic acid and Pyrexia
| Article | Year |
|---|---|
[Clinical trial on ibandronate in patients with tumor-associated hypercalcemia].
Topics: Bone Neoplasms; Breast Neoplasms; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Humans; Hypercalcemia; Ibandronic Acid; Lung Neoplasms; Male; Middle Aged; Multiple Myeloma; Phosphorus; Pruritus | 2004 |
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.
Topics: Adult; Aged; Aged, 80 and over; Bone Resorption; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Humans; Hypercalcemia; Ibandronic Acid; Male; Middle Aged; Nausea; Neoplasms; Recurrence; Regression Analysis; Thrombocytopenia; Treatment Outcome | 1996 |